NCT01215552View on ClinicalTrials.gov

Study of the Inhibition of [11C]R-rolipram Binding to Brain Phosphodiesterase - 4 (PDE-4) by HT-0712

PHASE1TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

January 31, 2011

Conditions
Healthy Elderly Volunteers
Interventions
DRUG

HT-0712

A range of single oral dose levels will be explored, utilizing 5mg and 25mg strength capsules

Trial Locations (1)

11973

Brookhaven National Laboratory, Upton

Sponsors
All Listed Sponsors
lead

Dart NeuroScience, LLC

INDUSTRY

NCT01215552 - Study of the Inhibition of [11C]R-rolipram Binding to Brain Phosphodiesterase - 4 (PDE-4) by HT-0712 | Biotech Hunter | Biotech Hunter